Nuvation Bio Inc (NUVB) stock is lower by -56.47% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NUVB stock a score of 33 out of a possible 100.
That rank is influenced by a long-term technical score of 1. NUVB's rank also includes a short-term technical score of 8. NUVB has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on NUVB!